Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-06

Clinical Trial Update: Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women [Phase 4]

View source ↗

Summary

This Phase 4 trial comparing ferric carboxymaltose to iron sucrose for treating iron-deficiency anemia in pregnant women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric carboxymaltose (ferric carboxymaltose)
  • Iron sucrose (iron sucrose)

Snippet

Sponsor: CMH Multan Institute of Medical Sciences | Conditions: Iron Deficiency Anemia (IDA), Pregnancy | Phase 4 | Status: COMPLETED